Powder: -20℃ for 3 years. In solvent: -80℃ for 1 year.
Synonyms
SB-641257
Description
Revaprazan is a novel, selective potassium-competitive acid blocker, to be specific, it reversibly inhibits gastric H(+)/K(+)-ATPase and shows effective acid suppression comparable to PPIs.